Health TrialsbyHealthPanel

Telecommunication Technology-based Online Survey

ConditionsRisk FactorsPolypharmacyDrug InteractionsSelf MedicationCOVID-19
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTomsk National Research Medical Center of the Russian Academy of Sciences

About this trial

The aim of this study is to identify and assess new health-associated risk factors, including clinical-pharmacological risk factors. The cohort is built using telecommunication approaches. The associations between clinical-pharmacological, social, demographic, behavioral, and environmental characteristics will be assessed. The continuous depersonalized online survey is performed using the original informational resources in the form of specially designed web-site aimed at identification and assessment of population-based pharmacotherapy patterns including characteristics of self-medication, biologically active food supplement intake, polypharmacy, and adverse drug-drug interactions in the people residing in the ecological conditions of various regions of the country. The invitations to participate in the online survey are sent via the SMS messages using the SMS-Target tool provided by OOO T2 Mobile Company. The survey is performed online at www.zdorov.tpu.ru and www.zdorov.expert both specifically designed for questionnaire publication and data accumulation.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

age of 18 years and older

signing the informed concent form online

completion of the entire questionnaire

Disqualifiers

age under 18 years

refuse to sign the informed concent form

Trial population

Nonstructured population aged 18 years and older willing to complete the entire questionnaire and signing the informed concent form.

Trial design

Design model

Ecologic or community

Time perspective

Cross-sectional

Treatments tested in this trial

  • Online Survey

    Other intervention

    The participants of the study undergo the online survey at www.zdorov.tpu.ru and www.zdorov.expert.

  • Genetic Testing

    Diagnostic test

    Genetic testing will be performed in subgroup of survey respondents willing to participate in the study of polymorphisms of genes involved in drug metabolism or affecting biological effects of medications including CYP2D6, ACE, UGT1A1, CYP2C9, and CYP2C19.

Treatment groups

2,000 Participants
are divided into 1 treatment group
Group A: Non-structured population2 interventions

Trial outcomes

Primary outcomes

1

Incidence of serious drug-drug interactions (percent)

Incidence of serious drug-drug interactions (DDIs) is assessed as a percentage (%) of completed survey questionnaires associated with serious DDIs relative to the size of respondent population.

Time frame
Five years
2

Median number of serious drug-drug interactions (n)

Median number of serious drug-drug interactions is assessed per one completed survey questionnaire containing information on pharmacotherapy.

Time frame
Five years

Secondary outcomes

1

Incidence of polypharmacy (percent)

Polypharmacy refers to using five or more medications. Incidence of polypharmacy is assessed as a percentage (%) of completed survey questionnaires reporting polypharmacy relative to the size of respondent population.

Time frame
Five years
2

Incidence of MRI administration (percent)

Incidence of magnetic resonance tomography (MRI) administration is assessed as a percentage (%) of completed survey questionnaires where respondents report the fact of undergoing MRI procedure for the past two years relative to the size of respondent population.

Time frame
Two years
3

Incidence of CT administration (percent)

Incidence of computed tomography (CT) administration is assessed as a percentage (%) of completed survey questionnaires where respondents report the fact of undergoing CT procedure for the past two years relative to the size of respondent population.

Time frame
Two years
4

Incidence of diagnostic ultrasound administration (percent)

Incidence of diagnostic ultrasound administration is assessed as a percentage (%) of completed survey questionnaires where respondents report the fact of undergoing ultrasonography procedure for the past two years relative to the size of respondent population.

Time frame
Two years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tomsk National Research Medical Center of the Russian Academy of Sciences

Lead sponsor

Source ClinicalTrials.gov
Apply now